护理学报 ›› 2022, Vol. 29 ›› Issue (19): 25-29.doi: 10.16460/j.issn1008-9969.2022.19.025
肌萎缩侧索硬化患者流涎症评估方法的研究进展
赵顺杰1, 白莎1, 王恬1, 李哲2, 郭君2
- 1.郑州大学护理与健康学院,河南 郑州 450001;
2.郑州大学第五附属医院,河南 郑州 450052
摘要： 目的 对肌萎缩侧索硬化患者流涎症的评估方法进行综述,为临床评估及相应工具的研发提供参考。方法 检索国内外相关文献,从流涎症的概念、病因及评估方法等角度进行分析和总结。结果 流涎症已成为肌萎缩侧索硬化患者常见的非运动症状之一,与延髓功能受损有关,长期流涎会损害身心健康、降低生活质量。评估方法主要有临床评估法、客观评估法和主观评估法3种。结论 临床评估法、主观评估法为医护人员常用的评估方法,但国内对肌萎缩侧索硬化患者流涎症的临床评估内容较局限、对现有流涎评估工具的使用意识淡薄,且国内缺乏本土化的肌萎缩侧索硬化患者流涎评估工具等。
中图分类号:
- R473.74
| [1] Oliveira AF, Silva GA, Almeida DM.Application of Botulinum Toxin to Treat Sialorrhea in Amyotrophic Lateral Sclerosis Patients: A Literature Review[J]. Einstein (Sao Paulo),2016,14(3):431-434.DOI:10.1590/S1679-45082016RB3594. [2] McGeachan AJ, Hobson EV, Al-Chalabi A, et al. A Multicentre Evaluation of Oropharyngeal Secretion Management Practices in Amyotrophic Lateral Sclerosis[J]. Amyotroph Lateral Scler Frontotemporal Degener,2017,18(1/2):1-9. DOI:10.1080/21678421.2016.1221433. [3] Steffen A, Jost W, Bäumer T, et al.Hypersalivation: Update of the German S2k Guideline (AWMF) in Short Form[J]. J Neural Transm (Vienna),2019,126(7):853-862. DOI:10.1007/s00702-019-02000-4. [4] Banfi P, Ticozzi N, Lax A, et al.A Review of Options for Treating Sialorrhea in Amyotrophic Lateral Sclerosis[J]. Respir Care,2015,60(3):446-454.DOI:10.4187/respcare.02856. [5] Garuti G, Rao F, Ribuffo V, et al.Sialorrhea in Patients with ALS: Current Treatment Options[J]. Degener Neurol Neuromuscul Dis,2019,9:19-26. DOI:10.2147/DNND.S168353. [6] Mcgeachan AJ, Mcdermott CJ.Management of Oral Secretions in Neurological Disease[J]. Pract Neurol, 2017,17(2):96-103. DOI:10.1136/practneurol-2016-001515. [7] Varley LP, Denieffe S, O'Gorman C, et al. A Systematic Review of Noninvasive and Invasive Sialorrhoea Management[J]. J Clin Nurs,2019,28(23/24):4190-4206. DOI:10.1111/jocn.15009. [8] Varley LP, Gooney M, Denieffe S, et al.Sialorrhoea Management Practices in Residential Older Adults Care Settings: A Qualitative Study[J]. J Nurs Manag,2021,29(5):989-997. DOI:10.1111/jonm.13236. [9] 王松灵,窦慧昕,秦力铮,等.流唾症的病因、诊断与治疗[J]. 口腔疾病防治, 2019,27(8):477-484. DOI:10.12016/j.issn.2096-1456.2019.08.001. [10] 王景刚,贠国俊,李庆云,等.儿童病理性流涎诊疗进展[J]. 中华物理医学与康复杂志,2021,43(3):276-279. DOI:10.3760/cma.j.issn.0254-1424.2021.03.022. [11] Danel-Brunaud V, Touzet L, Chevalier L, et al.Ethical Considerations and Palliative Care in Patients with Amyotrophic Lateral Sclerosis: A Review[J].Rev Neurol (Paris),2017,173(5):300-307.DOI:10.1016/j.neurol.2017.03.032. [12] Dash RP, Babu RJ, Srinivas NR.Two Decades-Long Journey from Riluzole to Edaravone: Revisiting the Clinical Pharmacokinetics of the Only Two Amyotrophic Lateral Sclerosis Therapeutics[J]. Clin Pharmacokinet,2018,57(11):1385-1398. DOI:10.1007/s40262-018-0655-4. [13] Tye CB, Gardner PA, Dion GR, et al.Impact of Fiberoptic Endoscopic Evaluation of Swallowing Outcomes and Dysphagia Management in Neurodegenerative Diseases[J]. Laryngoscope,2021,131(4):726-730.DOI:10.1002/lary.28791. [14] Mezzedimi C, Vinci E, Giannini F, et al.Correlation Between Dysphonia and Dysphagia Evolution in Amyotrophic Lateral Sclerosis Patients[J]. Logoped Phoniatr Vocol,2021,46(3):118-125. DOI:10.1080/14015439.2020.1771766. [15] Morgante F, Bavikatte G, Anwar F, et al.The Burden of Sialorrhoea in Chronic Neurological Conditions: Current Treatment Options and the Role of IncobotulinumtoxinA (Xeomin®)[J]. Ther Adv Neurol Disord,2019,12:1756286419888601. DOI:10.1177/1756286419888601. [16] Driskell LD, York MK, Heyn PC, et al.A Guide to Understanding the Benefits of a Multidisciplinary Team Approach to Amyotrophic Lateral Sclerosis (ALS) Treatment[J]. Arch Phys Med Rehabil, 2019, 100(3):583-586.DOI:10.1016/j.apmr.2018.05.002. [17] Klavžar P, Koritnik B, Leonardis L, et al.Improvements in The Multidisciplinary Care Are Beneficial for Survival in Amyotrophic Lateral Sclerosis(ALS): Experience from a Tertiary ALS Center[J]. Amyotroph Lateral Scler Frontotemporal Degener, 2020, 21(3/4):203-208. DOI:10.1080/21678421.2020.1746809. [18] Ichikawa K, Sakuma S, Yoshihara A, et al.Relationships between the Amount of Saliva and Medications in Elderly Individuals[J]. Gerodontology, 2011, 28(2):116-120. DOI:10.1111/j.1741-2358.2009.00358.x. [19] Kohler PF, Winter ME.A Quantitative Test for Xerostomia. the Saxon Test, an Oral Equivalent of the Schirmer Test[J].Arthritis Rheum,1985,28(10):1128-1132. DOI:10.1002/art.1780281008. [20] Paracka L, Kollewe K, Klietz M, et al.IncobotulinumtoxinA for Hypersalivation in Patients with Amyotrophic Lateral Sclerosis: An Open-label Single-centre Study[J]. J Neural Transm (Vienna),2019, 126(10):1341-1345. DOI:10.1007/s00702-019-02044-6. [21] 李超,陈素玲,汤清秋,等.超声引导下A型肉毒毒素注射治疗神经源性吞咽障碍患者流涎症的疗效观察[J].中华物理医学与康复杂志, 2020, 42(11):999-1002. DOI:10.3760/cma.j.issn.0254-1424.2020.11.009. [22] Rapp D.Management of Drooling[J]. Dev Med Child Neurol,1988,30(1):128-129.DOI:10.1111/j.1469-8749.1988.tb04738.x. [23] Reddihough D, Johnson H, Staples M, et al.Use of Benzhexol Hydrochloride to Control Drooling of Children with Cerebral Palsy[J]. Dev Med Child Neurol, 1990, 32(11):985-989. DOI:10.1111/j.1469-8749.1990.tb08121.x. [24] Jongerius PH, van den Hoogen FJ, van Limbeek J, et al. Effect of Botulinum Toxin in the Treatment of Drooling: A Controlled Clinical Trial[J]. Pediatrics,2004,114(3):620-627. DOI:10.1542/peds.2003-1104-L. [25] Rashnoo P, Daniel SJ.Drooling Quantification: Correlation of Different Techniques[J]. Int J Pediatr Otorhinolaryngol,2015,79(8):1201-1205. DOI:10.1016/j.ijporl.2015.05.010. [26] Mcgeachan AJ, Hobson EV, Shaw PJ, et al.Developing an Outcome Measure for Excessive Saliva Management in MND and an Evaluation of Saliva Burden in Sheffield[J]. Amyotroph Lateral Scler Frontotemporal Degener,2015,16(1/2):108-113.DOI:10.3109/21678421.2014.951942. [27] van Hulst K, Lindeboom R, van der Burg J, et al. Accurate Assessment of Drooling Severity with the 5-Minute Drooling Quotient in Children with Developmental Disabilities[J]. Dev Med Child Neurol,2012, 54(12):1121-1126. DOI:10.1111/j.1469-8749.2012.04428.x. [28] Van Hulst K, Van Der Burg JJ,Jongerius PH,et al. Changes in Severity and Impact of Drooling after Submandibular Gland Botulinum Neurotoxin A Injections in Children with Neurodevelopmental Disabilities[J]. Dev Med Child Neurol,2020,62(3):354-362. DOI:10.1111/dmcn.14391. [29] Thomas-Stonell N, Greenberg J.Three Treatment Approaches and Clinical Factors in The Reduction of Drooling[J].Dysphagia,1988,3(2):73-78. DOI:10.1007/BF02412423. [30] Chowdhury A, Mukherjee A, Sinharoy U, et al.Non-motor Features of Amyotrophic Lateral Sclerosis: A Clinic-based Study[J]. Ann Indian Acad Neurol,2021,24(5):745-753. DOI:10.4103/aian.AIAN_51_21. [31] Kok SE, Erasmus CE, Scheffer ART, et al.Effectiveness of Submandibular Duct Relocation in 91 Children with Excessive Drooling: A Prospective Cohort Study[J]. Clin Otolaryngol,2018,43(6):1471-1477. DOI:10.1111/coa.13188. [32] Beswick E, Forbes D, Hassan Z, et al.A Systematic Review of Non-Motor Symptom Evaluation in Clinical Trials for Amyotrophic Lateral Sclerosis[J]. J Neurol, 2022,269(1):411-426. DOI:10.1007/s00415-021-10651-1. [33] Cedarbaum JM, Stambler N, Malta E, et al.The ALSFRS-R: A Revised ALS Functional Rating Scale That Incorporates Assessments of Respiratory Function. BDNF ALS Study Group (Phase III)[J]. J Neurol Sci,1999,169(1/2):13-21. DOI:10.1016/s0022-510x(99)00210-5. [34] Bakker LA, Schröder CD, van Es MA, et al. Assessment of the Factorial Validity and Reliability of the ALSFRS-R: A Revision of Its Measurement Model[J]. J Neurol, 2017,264(7):1413-1420. DOI:10.1007/s00415-017-8538-4. [35] Cazzolli PA, Brooks BR, Lewarski JS, et al.Oral Secretion Scale (OSS) Score in Amyotrophic Lateral Sclerosis(ALS) Patients is Associated with Tolerance of Non-invasive Positive Pressure Ventilation(NPPV), Need for Hospice or Transition to Tracheal Positive Pressure Ventilation (TPPV) and Survival[J]. Neurology,2010,74(9):A181. [36] Abdelnour-Mallet M, Du Montcel ST, Cazzolli PA, et al.Validation of Robust Tools to Measure Sialorrhea in Amyotrophic Lateral Sclerosis: A Study in a Large French Cohort[J]. Amyotroph Lateral Scler Frontotemporal Degener,2013,14(4):302-307. DOI:10.3109/21678421.2012.735238. [37] Cazzolli PA, Brooks BR, Nakayama Y, et al.The Oral Secretion Scale and Prognostic Factors for Survival in Subjects with Amyotrophic Lateral Sclerosis[J]. Respir Care,2020,65(8):1063-1076. DOI:10.4187/respcare.07005. [38] Arbouw ME, Movig KL, Koopmann M, et al.Glycopyrrolate for Sialorrhea in Parkinson Disease: A Randomized, Double-blind, Crossover Trial[J]. Neurology, 2010, 74(15):1203-1207. DOI:10.1212/WNL.0b013e3181d8c1b7. [39] Assouline A, Levy A, Abdelnour-Mallet M, et al.Radiation Therapy for Hypersalivation:A Prospective Study in 50 Amyotrophic Lateral Sclerosis Patients[J].Int J Radiat Oncol Biol Phys,2014,88(3):589-595.DOI:10.1016/j.ijrobp.2013.11.230. [40] Smith RA, Macklin EA, Myers KJ, et al.Assessment of Bulbar Function in Amyotrophic Lateral Sclerosis: Validation of a Self-report Scale (Center for Neurologic Study Bulbar Function Scale)[J]. Eur J Neurol,2018,25(7):907-e66. DOI:10.1111/ene.13638. |
| [1] | 张涌静, 申华平, 郭庆峰, 王娟. 置入PICC并带管出院癌症患者基于mHealth技术延续护理的效果观察[J]. 护理学报, 2022, 29(9): 68-72. |
| [2] | 黄盼盼, 程红, 张迎红, 王艳, 张连生. 基于4R危机管理理论构建互联网+护理服务风险管理评价指标体系[J]. 护理学报, 2022, 29(9): 16-20. |
| [3] | 李翔, 冯英璞, 孟晓静, 周立民, 霍晓冉, 许梦敏, 王昊. 脑卒中患者口腔健康管理的最佳证据总结[J]. 护理学报, 2022, 29(9): 36-41. |
| [4] | 麦剑欣, 陈婉华, 聂莎. SBAR模式在无抽搐电痉挛治疗患者转运交接中的应用[J]. 护理学报, 2022, 29(9): 21-25. |
| [5] | 刘天贶, 龙玉娟, 刘欢, 刘逸文. ICU患者不同部位黏膜压力性损伤的特征及护理研究进展[J]. 护理学报, 2022, 29(8): 35-39. |
| [6] | 陈芳芳, 叶灵晓, 胡雁, 郑亚华, 李娟, 楼钶楠, 刘梅, 胡康丽. 心脏起搏器术后患者早期运动康复的最佳证据总结[J]. 护理学报, 2022, 29(8): 53-58. |
| [7] | 王琪, 刘腊梅, 陈莉娜, 阙晓玲, 苏绍玉. 基于结构-过程-结果模型儿童支气管镜围术期专科护理质量敏感指标的构建[J]. 护理学报, 2022, 29(8): 69-74. |
| [8] | 田云伟, 李善玲, 田文雯, 李维果, 邵琴. 护理人员接近失误事件认知的质性研究[J]. 护理学报, 2022, 29(7): 32-35. |
| [9] | 王锐, 李智, 杨芹, 王春立, 李凤婷, 王旭梅. 1型糖尿病患儿居家低血糖识别及处理最佳证据总结[J]. 护理学报, 2022, 29(7): 50-56. |
| [10] | 罗玉勤, 李孟璇, 程秋, 王婷, 郑晶予, 方进博, 龚玉萍. 血液肿瘤患者化疗后肛周感染危险因素病例对照研究[J]. 护理学报, 2022, 29(7): 7-11. |
| [11] | 朱飞, 路潜, 齐娟, 边颖, 庞立莎, 刘春蕾. 育龄期乳腺癌患者生育意愿的质性研究[J]. 护理学报, 2022, 29(7): 23-26. |
| [12] | 邱昌翠, 于晓丽, 冯亚婷, 杨正雄, 徐婷, 朱晓萍. ICU营养支持患者再喂养综合征风险评估及预防干预研究[J]. 护理学报, 2022, 29(7): 57-62. |
| [13] | 李珂, 韩舒羽, 杨振楠, 麦智德. 急诊给药安全护理干预策略的研究进展[J]. 护理学报, 2022, 29(7): 36-39. |
| [14] | 刘纬华, 张红梅, 白文辉, 卢颖, 苗晓慧. 研究型医院护理学科建设评估指标体系的构建[J]. 护理学报, 2022, 29(6): 20-25. |
| [15] | 廖敏, 李金花, 陈婕君, 程静, 李星凤. 乳腺癌患者基于互联网平台康复预警模型干预的效果观察[J]. 护理学报, 2022, 29(6): 73-78. |
|